nformation in this press release includes certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to potential market for COPPERTONE(R) NUTRASHIELD(TM). Forward-looking statements relate to expectations or forecasts of future events. Schering-Plough does not assume the obligation to update any forward-looking statement. Many factors could cause actual results to differ materially from Schering-Plough's forward-looking statements, including market forces, economic factors, product availability, patent and other intellectual property protection, current and future branded, generic or over-the-counter competition, the regulatory process, and any developments following regulatory approval, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the third quarter 2008 10-Q, filed October 29, 2008.
'/>"/>SOURCE Schering-Plough Corporation Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 Related medicine news :1.
Brooke Franchise Corporation Announces Selected July Results2.
Appropriate timing in the use of breast shields in children can further reduce MDCT radiation dose3.
Col. Robert E. Shields Joins Palmetto GBAs Board of Directors4.
Football helmet shields can protect against a kick in the face5.
Drug Shields Mice From Emphysema6.
Study Shows Exercise Shields Against Osteoporosis7.
Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference8.
Equipping your Sales Force to Influence Hospital Formulary Decision-Makers9.
Hospitals and the Coalition to Protect Floridas Drivers Applaud Lawmakers for Reviving No-Fault Insurance10.
Makers of OTC Cough and Cold Medicines Announce Voluntary Withdrawal of Oral Infant Medicines11.
Drug Makers Withdraw Cough, Cold Meds for Infants